- Arthroben® Unflavored/ Unsweetened 240 g (8.5 oz)
- Product Size: 240 g (8.5 oz)
- Servings Per Container:
- Additional information
Comment by Dr. Nielsen, this product comes in Green Apple flavor that is Stevia and TOXIC. use only unflavored, Read the book, Stevia Deception.
Arthroben® is a safe, effective, non-NSAID, anti-inflammatory formula offered in a highly absorbable, . Its combination of nutrients work to reduce inflammation, stimulate connective tissue repair and increase joint mobility and function.
Benefits of Arthroben® include:
• Reduces inflammation
• Balanced inhibition of COX-1, COX-2, 5-LOX
• Offers potent antioxidant protection to reduce joint deterioration
• Increases joint mobility and function
• Stimulates joint repair, and provides nutritional building blocks for cartilage, ligaments (and skin)
• Not associated with the negative side effects that are commonly seen with NSAIDs & other drugs
• Safe for patients on warfarin (Coumadin)
• Little or no effect on prothrombin times (PT)
Made with non-GMO ingredients.
For the dietary management of the metabolic processes of Osteoarthritis
Arthroben’s four-pronged approach to the dietary management of osteoarthritis:
1. Reduces inﬂammation—balanced COX and LOX inhibition**
2. Potent antioxidant protection to reduce joint degeneration**
3. Reduces stiffness, increases joint mobility and function**
4. Stimulates connective tissue repair**
Key Actives in Arthroben®
A proprietary blend of the ﬂavonoids baicalin and catechin that was shown to be as effective as naproxen in managing knee osteoarthritis and produced improvements in 87% of patients.
Dual Action of bioﬂavonoids:
1. Balanced inhibition of COX-1, COX-2 and 5-LOX pathways. This balanced down-regulation, though weaker than traditional NSAIDs and selective COX2 inhibitor drugs, is not associated with the side eff ects commonly seen with selective COX inhibitors.**
2. Acts as a strong antioxidant to limit free radicals and oxidative damage to cartilage and other connective tissue of the joints.**
FORTIGEL® & VERISOL®: Speciﬁc Bioactive Collagen Peptides® derived from a patented process of hydrolysis of type I collagen. These ingredients boost anabolic processes in connective tissues and provide building blocks for all collagen in the body.
• 16 human clinical trials (approximately 2,800 subjects) displayed a positive effect on joint health
• Reduced need for analgesics
• Increased joint mobility
• Improved radiographic markers of cartilage health VERISOL®
• Tested in two recent human clinical studies for its effects on collagen metabolism of the skin
• Improved skin elasticity and collagen type I content
For the dietary management of osteoarthritis and musculoskeletal inflammation related to athletic or other physical activityMEDICAL FOODArthroben™EFFECTIVE•As effective as naproxen in managing knee osteoarthritis1•Providesincreased mobility and function•Stimulates connective tissue repairSAFE•Gentle on the GI tract2•Balanced inhibition of COX-1, COX-2, and 5-LOX pathways3Arthroben™Amount per servingServing size11 gFlavocoxid250 mgFORTIGEL®5 gVERISOL®2.5 gA safe, effective, non-NSAID anti-inflammatory for osteoarthritis patientsArthroben™Medical Food for the dietary management of osteoarthritis and musculoskeletal inflammation related to athletic or other physical activityINGREDIENTSARTHROBEN™ is available in delicious tasting apple and lemon-lime flavored powders, as well as an unflavored/unsweetened powder.RECOMMENDED USEMix 11 grams (approx. 1½ tablespoons) in 8 ounces of water per day, or as directed by a physicianCopyright © 2013 Designs for Health, Inc. REFERENCES:1. Levy R, et al. Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study. Nutr Res. 2009 May; 29(5):298-304.2. Burnett BP, et al. Safety Evaluation of a Combination, Defined Extract of Scutellaria baicalensis and Acacia catechu. J Food Biochem. 2007;31:797-825. 3. Burnett BP, et al. A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation. J Med Food. 2007 Sep;10(3):442-51. 4. Adam M, What effects do gelatine preparations have? Therapy of osteoarthritis (in German), Therapiewoche 1991, 41, 2456-2461. 5. Clark, Sebastianelli et al., 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain, Current Medical Research and Opinion, Vol. 24, No. 5, 2008, 1485 – 1496.6. Edward J. Frech and Mae F. Go. Treatment and chemoprevention of NSAID-associated gastrointestinal complications. Therapeutics and Clinical Risk Management, 2009, pp. 65-73. 7. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am. J. Med. 1998 105(1B):31S–38S. 8. Vonkeman HE and van de Laar MAFJ. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum. 2010 39(4):294– 312. 9. Back M, et al. Cyclooxygenase 2 inhibitors and cardiovascular risk in a nationwide cohort study after the withdrawal of rofecoxib. Eur Heart J. 2011;21. [Epub ahead of print] 10. Moodley I. Review of the cardiovascular safety of COXIBs compared to NSAIDS. Cardiovasc J Afr. 2008 Mar Apr 19(2):102 7. 11. Belknap SM. NSAIDs were associated with increased risk for mortality, regardless of time since first MI. Ann Intern Med. 2013 Jan 15;158(2):JC10. 12. Roubille C, et al. Cardiovascular adverse effects of anti-inflammatory drugs. Antiinflamm Antiallergy Agents Med Chem. 2012 Dec 31. 13. Arch Intern Med. 2000;160(6):777-784. doi:10.1001/archinte.160.6.777. 14. Singh Gurkirpal, MD, Recent Considerations in Nonsteroidal Anti-Inflammatory Drug Gastropathy, The American Journal of Medicine, July 27, 1998, p. 31S 15. Wolfe M. MD, Lichtenstein D. MD, and Singh Gurkirpal, MD, Gastrointestinal Toxicity of Nonsteroidal Anti-inflammatory Drugs, The New England Journal of Medicine, June 17, 1999, Vol. 340, No. 24, pp. 1888-1889. 16. Larson AM, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005 42(6):1364–72. 17. Bessems JG and Vermeulen NP. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol. 2001 31(1):55–138. 18. Patrício JP, et al. Relative Cardiovascular and Gastrointestinal Safety of Non-selective Non-steroidal Anti-inflammatory Drugs Versus Cyclo-oxygenase-2 Inhibitors: Implications for Clinical Practice. Clin Drug Investig. 2013 Jan 22. 19. T.E. McAlindon, M. Nuite, N. Krishnan, R. Ruthazer, L.L. Price, D. Burstein, J. Griffith, K. Flechsenhar, Change in knee osteoarthritis cartilage detected by delayed gadolinium enh
|Dimensions||5.0 × 4.0 × 4.0 in|